Is it coincidental or correlative between reversible splenial lesion syndrome and atrial septal defect?: A case report

Medicine (Baltimore). 2020 Oct 23;99(43):e22920. doi: 10.1097/MD.0000000000022920.

Abstract

Rationale: Reversible splenial lesion syndrome (RESLES) is a recently identified clinico-radiological syndrome, the etiology is miscellaneous. Atrial septal defect (ASD) as an underlying etiology for RESLES has not been reported. We first report a rare case of RESLES associated with ASD. The clinical, radiological, and ultrasonic profiles were presented and the pathophysiological mechanism was analyzed.

Patient concerns: A 23-year-old man presented with headache, drowsiness, occasional paraphasia, and paroxysmal dry cough. Brain magnetic resonance imaging (MRI) on admission showed an ovoid isolated lesion in the splenium of corpus callosum, which exhibited hyperintensity on diffusion-weighted imaging and hypointensity on apparent diffusion coefficient, and completely disappeared on the follow-up MRI 14 days later. ASD was found by transthoracic echocardiography, Right-to-left shunts were detected on color Doppler of transesophageal echocardiography, and microemboli were captured by transcranial Doppler ultrasound.

Diagnoses: According to his clinical history and imaging results, we confirmed the diagnosis of RESLES associated with ASD.

Interventions: The patient was treated by oral aspirin and lopidogrel sulfate to inhibit platelet aggregation. In addition, oral nimodipine to suppress vasoconstriction.

Outcomes: After 14 days treatment, all the symptoms presenting on admission resolved completely. Subsequently, a repair surgery of ASD under thoracoscopy was successfully performed.

Lessons: To our knowledge, this is the first reported case of ASD may be an underlying etiology for RESLES and need require an etiotropic treatment.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Antihypertensive Agents / administration & dosage
  • Antihypertensive Agents / therapeutic use
  • Aspirin / administration & dosage
  • Aspirin / therapeutic use
  • Brain Diseases / diagnostic imaging
  • Brain Diseases / etiology*
  • Brain Diseases / pathology
  • Corpus Callosum / diagnostic imaging*
  • Corpus Callosum / pathology
  • Diffusion Magnetic Resonance Imaging / methods*
  • Drug Combinations
  • Drug Therapy, Combination
  • Echocardiography / methods
  • Follow-Up Studies
  • Headache / etiology
  • Heart Septal Defects, Atrial / complications*
  • Heart Septal Defects, Atrial / diagnostic imaging
  • Heart Septal Defects, Atrial / drug therapy
  • Heart Septal Defects, Atrial / surgery
  • Humans
  • Lopinavir / administration & dosage
  • Lopinavir / therapeutic use
  • Male
  • Nimodipine / administration & dosage
  • Nimodipine / therapeutic use
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / therapeutic use
  • Ritonavir / administration & dosage
  • Ritonavir / therapeutic use
  • Syndrome
  • Treatment Outcome
  • Ultrasonography, Doppler, Transcranial / methods
  • Young Adult

Substances

  • Antihypertensive Agents
  • Drug Combinations
  • Platelet Aggregation Inhibitors
  • lopinavir-ritonavir drug combination
  • Lopinavir
  • Nimodipine
  • Ritonavir
  • Aspirin